C-NRX

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com

15:33:43 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NRX - V	8.0	0.70	·	0.73	0.5	0.72	-0.03	-4.0	35.9	25	29	0.74 0.74 0.72	0.87 0.46	15:41:46	Mar 14	15 min RT 2¢
TSX-V - V	8.0	0.70	·	0.73	0.5	0.72	-0.03	-4.0	22.3	16	14	0.74 0.74 0.72	0.87 0.46	15:41:46		15 min
NEO ATS - U						0.72	-0.03	-4.0	11.0	8	10	0.74 0.74 0.72		15:41:33		15 min
CX2 - H						0.72	-0.03	-4.0	2.5	2	2	0.72 0.72 0.72		15:41:33		15 min
CXD - D						0.75			0.006		1			Mar 17		15 min
TriAct - M						0.75			0.2	0	2					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 29

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:41:46	V	0.72	-0.03	500	79 CIBC	1 Anonymous	K
15:41:46	V	0.72	-0.03	1,500	124 Questrade	1 Anonymous	K
15:41:46	V	0.72	-0.03	1,000	124 Questrade	1 Anonymous	K
15:41:33	V	0.72	-0.03	70	19 Desjardins	36 Latimer
15:41:33	U	0.72	-0.03	1,000	7 TD Sec	1 Anonymous	K
15:41:33	U	0.72	-0.03	500	2 RBC	1 Anonymous	K
15:41:33	H	0.72	-0.03	2,000	124 Questrade	1 Anonymous	K
15:41:33	U	0.72	-0.03	500	2 RBC	1 Anonymous	K
15:41:33	U	0.72	-0.03	1,000	7 TD Sec	1 Anonymous	K
11:41:01	M	0.70	-0.05	150	2 RBC	1 Anonymous	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-03-14 16:42	C:NRX	0.65	News Release200	Nurexone completes preclinical study for ExoPTEN
2025-02-27 16:03	C:NRX	0.57	News Release200	NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award
2025-02-14 16:03	C:NRX	0.61	News Release200	NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
2025-02-05 18:29	C:NRX	0.58	News Release200	Nurexone Biologic forms U.S.-based subsidiary
2025-02-03 17:16	C:NRX	0.58	Private Placement250	Nurexone Biologic 856,996-share private placement
2025-01-21 19:03	C:NRX	0.62	News Release200	Nurexone closes $479,917 private placement
2025-01-08 18:42	C:NRX	0.63	News Release200	Nurexone Biologic acquires master cell bank
2024-12-06 17:31	C:NRX	0.73	News Release200	Nurexone talks up ExoPTEN preclinical results
2024-11-27 07:11	C:NRX	0.70	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-11-27 07:11	C:NRX	0.70	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-11-27 07:01	C:NRX	0.70	News Release200	NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
2024-11-13 16:28	C:NRX	0.63	News Release200	Nurexone's ExoPTEN therapy receives EMA orphan status
2024-11-12 19:56	C:NRX	0.60	Private Placement250	Nurexone Biologic 3,159,359-share private placement
2024-11-01 17:04	C:NRX	0.67	News Release200	Nurexone closes final tranche of placement
2024-09-26 18:08	C:NRX	0.57	News Release200	Nurexone closes $1.61M first tranche of financing
2024-09-06 16:48	C:NRX	0.56	News Release200	Nurexone finds one-week window for ExoPTEN use
2024-08-28 19:06	C:NRX	0.63	News Release200	Nurexone spends $510,000 (U.S.) on R&D in Q2 2024
2024-08-28 14:41	C:NRX	0.65	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-08-27 17:18	C:NRX	0.65	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-08-27 17:18	C:NRX	0.65	SEDAR Interim MD & A813	SEDAR Interim MD & A

Date ET

Symbol

Price

Type

Headline

2025-03-14 16:42

C:NRX

0.65

News Release

Nurexone completes preclinical study for ExoPTEN

2025-02-27 16:03

C:NRX